X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1614) 1614
humans (1208) 1208
antifungal agents - pharmacology (951) 951
microbiology (859) 859
echinocandins (850) 850
pharmacology & pharmacy (648) 648
echinocandins - pharmacology (645) 645
antifungal agents - therapeutic use (638) 638
microbial sensitivity tests (604) 604
caspofungin (592) 592
lipopeptides (586) 586
infectious diseases (525) 525
antifungal agents (478) 478
fluconazole (444) 444
candida - drug effects (431) 431
drug resistance, fungal (424) 424
amphotericin-b (399) 399
echinocandins - therapeutic use (381) 381
male (374) 374
candidiasis - drug therapy (360) 360
micafungin (357) 357
voriconazole (339) 339
female (333) 333
mycology (320) 320
susceptibility (316) 316
bacterial infections and mycoses (311) 311
echinocandin (300) 300
candida (296) 296
candidiasis - microbiology (296) 296
resistance (288) 288
invasive candidiasis (281) 281
animals (278) 278
epidemiology (261) 261
candida albicans - drug effects (244) 244
middle aged (239) 239
candidiasis (234) 234
mycoses (228) 228
amphotericin b (222) 222
adult (220) 220
anidulafungin (219) 219
candida - isolation & purification (219) 219
infections (213) 213
amphotericin b - pharmacology (206) 206
fungi (204) 204
aged (195) 195
lipopeptides - pharmacology (187) 187
health aspects (184) 184
mycoses - drug therapy (179) 179
treatment outcome (177) 177
fluconazole - pharmacology (176) 176
in-vitro (171) 171
antifungal agents - administration & dosage (169) 169
candidemia (165) 165
fungal proteins - genetics (163) 163
liposomal amphotericin-b (161) 161
albicans (160) 160
echinocandin resistance (158) 158
azoles (156) 156
blood-stream infections (155) 155
candida-albicans (155) 155
triazoles - pharmacology (152) 152
candida glabrata - drug effects (151) 151
mutation (151) 151
infection (145) 145
mortality (144) 144
aspergillosis (143) 143
fungal infections (143) 143
fungal-infections (143) 143
antifungal susceptibility (142) 142
peptides, cyclic - pharmacology (140) 140
yeast (139) 139
drug resistance (137) 137
mice (137) 137
aspergillosis - drug therapy (136) 136
amphotericin b - therapeutic use (135) 135
candida albicans (135) 135
drug therapy (134) 134
internal medicine (133) 133
therapy (132) 132
aspergillus (130) 130
candida - classification (130) 130
echinocandins - administration & dosage (130) 130
itraconazole (129) 129
analysis (126) 126
drug therapy, combination (126) 126
triazoles - therapeutic use (126) 126
research (125) 125
pharmacokinetics (124) 124
saccharomyces-cerevisiae (121) 121
immunology (119) 119
antifungal agents - pharmacokinetics (118) 118
in-vitro activity (118) 118
antifungal agents - adverse effects (116) 116
peptides, cyclic - therapeutic use (116) 116
polycyclic compounds (115) 115
surveillance (112) 112
microbial sensitivity tests - methods (111) 111
antifungal (109) 109
invasive fungal-infections (109) 109
antifungals (107) 107
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1835) 1835
Spanish (26) 26
French (21) 21
Japanese (15) 15
German (10) 10
Turkish (3) 3
Russian (2) 2
Chinese (1) 1
Czech (1) 1
Danish (1) 1
Dutch (1) 1
Estonian (1) 1
Italian (1) 1
Korean (1) 1
Norwegian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 01/2019, Volume 63, Issue 1
Candida auris is an emerging multidrug-resistant yeast that can cause serious invasive infections. The accurate and rapid assessment of antifungal resistance... 
Candida auris | echinocandin | ERG11 | resistance | azole | FKS | molecular beacons | MICROBIOLOGY | PHARMACOLOGY & PHARMACY
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 6/2013, Volume 56, Issue 12, pp. 1724 - 1732
Background. Fluconazole (FLC) resistance is common in C. glabrata and echinocandins are often used as first-line therapy. Resistance to echinocandin therapy... 
Antifungals | Azoles | Health outcomes | Microbial sensitivity tests | Mortality | Polyenes | Infections | Candida glabrata | ARTICLES AND COMMENTARIES | Genetic mutation | Blood | susceptibility | micafungin | resistance | echinocandin | CASPOFUNGIN | INFECTIOUS DISEASES | ASPERGILLUS-FUMIGATUS | MICROBIOLOGY | IMMUNOLOGY | CHANGING EPIDEMIOLOGY | IN-VITRO | ANTIFUNGAL AGENTS | 1,3-BETA-D-GLUCAN SYNTHASE | ALBICANS | BLOOD-STREAM INFECTIONS | INVASIVE CANDIDIASIS | Humans | Middle Aged | Child, Preschool | Infant | Male | Candidiasis - microbiology | Antifungal Agents - therapeutic use | Microbial Sensitivity Tests | Candidiasis - drug therapy | Aged, 80 and over | Adult | Female | Retrospective Studies | Child | Drug Resistance, Fungal | Echinocandins - pharmacology | Infant, Newborn | Glucosyltransferases - genetics | Antifungal Agents - pharmacology | Membrane Proteins - genetics | Treatment Outcome | Fungal Proteins - genetics | Mutation - genetics | Adolescent | Echinocandins - therapeutic use | Aged | Candida glabrata - genetics | Candida glabrata - drug effects | Complications and side effects | Drug resistance in microorganisms | Candidiasis | Gene mutations | Echinocandins | Dosage and administration | Genetic aspects | Research | Drug therapy | Risk factors | Fungal infections | Mutation | Drug resistance | Genes | Pesticides | Index Medicus | and Commentaries
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 12/2015, Volume 61, Issue 11, p. S612
Journal Article
PLoS Pathogens, ISSN 1553-7366, 09/2011, Volume 7, Issue 9, pp. e1002257 - e1002257
Journal Article
Journal Article